Virtual Investor Conferences, the proprietary virtual event series from OTC Markets Group Inc (OTCQX:OTCM), released the agenda for the upcoming CBD Biopharma Virtual Investor Conference. The free event is designed to connect individual and institutional investors, analysts and advisors with companies across a variety of industries. The program is scheduled to begin at 10:15 am ET, with the first live webcast at 10:30 AM ET, on July 9. Registration can be done here. The companies presenting at the live virtual event include Avicanna Inc (OTCQX: AVCNF) (TSX:AVCN), Cardiol Therapeutics Inc (OTCQX:CRTPF)(TSX: CRDL), Medipharm Labs Corp (OTCQX: MEDIF) (TSX:LABS), Willow Biosciences Inc (OTCQB:CANSF) (TSX: WLLW), Marijuana Company of America Inc (OTCQB:MCOA) and FinCanna Capital Corp (OTCQB:FNNZF) (CSE:CALI).
Talon Metals Corp (TSE:TLO) (OTCMKTS:TLOFF) released new details about the metallurgy of its Tamarack project that increases throughput and extends the mine life of the polymetallic orebody. A preliminary economic assessment from March 2020, which included 4.9 million tonnes of material in the mine plan, excluded 3.1 million tonnes of additional material as Talon was in the midst of developing a representative flowsheet. In the interim, Talon completed flowsheet development that indicated flotation sensitivity was unaffected by the additional material. The company is now progressing with an updated mine plan and economic analysis to reflect the positive results, it told shareholders Wednesday.
CytoDyn Inc (OTCQB:CYTY) said it will hold its annual general meeting of shareholders on July 22 in a virtual setting only due to the coronavirus outbreak. The biotechnology firm said the decision was to support the health and wellbeing of its employees, stockholders, and community. To access the virtual meeting please click the Virtual Stockholder Meeting link. To login to the virtual meeting, you have two options: Join as a “Guest” or Join as a “Stockholder.” If the “Stockholder” option is selected, participants will be required to have a control number and password to login to the virtual meeting. The password for the meeting is CYDY2020. The company reminded stockholders to vote their shares whether they plan to attend the virtual meeting or not.
BioSig Technologies Inc (NASDAQ:BSGM) and its subsidiary ViralClear Pharmaceuticals Inc announced a partnership Thursday with contract R&D and manufacturing company Albany Molecular Research Inc (AMRI) to investigate its drug merimepodib to fight SARS-CoV-2, the virus that causes Covid-19. The parties plan to evaluate the drug as a standalone treatment and in combination with other antiviral agents or immune modulators. Merimepodib has demonstrated broad-spectrum in vitro antiviral activity, including strong activity against SARS-CoV-2 in cell cultures, the company said.
EuroLife Brands Inc (CSE:EURO) (OTCPINK:EURPF), a vertically integrated company focused on the European hemp, cannabinoid, and health and wellness sector, announced Wednesday it has opened an additional retail location in Ingolstadt, Germany. The company also said that it and CWE European Holdings Inc are working together to secure multiple additional retail storefronts as EuroLife works with its European partners, distributors, and retail networks to expand its retail footprint and overall market share. Ingolstadt is located on the banks of the Danube in the center of Bavaria. It is home to some 150,000 residents, making it the fifth-largest city in Bavaria. The city is also part of the Munich Metropolitan Region.
American Resources Corporation (NASDAQ:AREC) announced Wednesday the expansion of its wholly owned subsidiary American Metals LLC. In addition, the company said it has selected its Deane Mining facility in Letcher County, Kentucky as its initial rail load out and logistics location for processed metals. American Metals said it is expanding its current metal recovery business and will aggregate, process and transport used steel to be recycled and sold to traditional and electric arc furnace steel production facilities.
Quantum Computing Inc (OTCQB:QUBT) is launching a series of free webinars featuring its Mukai quantum computing software execution platform designed to show how it can solve real-world optimization problems at breakthrough speed. The programs will be hosted by Steve Reinhardt, the company’s VP of business development and an expert in quantum software. The first session, titled, “The Value of QuOIR Running on the Mukai Platform; Use Cases and Examples” will be held at noon ET on July 14. The second session, “The Mukai ‘How To’ Webinar,” is scheduled for noon ET on July 21.
GlobeX Data Ltd (CSE:SWIS) (OTCQB:SWISF), the cyber security and privacy solutions provider, said that it will start promoting its Sekur anti-phishing encrypted email and messaging solution to “several sectors and targets” it has identified. The company is launching the Swiss-hosted secure communications solution in the US, followed by other countries. GlobeX is planning to target around 100,000 professionals in the legal, financial, medical and real estate sectors in the US. Sekur includes a self-destruct timer powered by the company’s encrypted email service. In late-July, GlobeX plans to offer Sekur for an introductory price of $9.99 per month per user, or $99.90 for the year. It will include 100 gigabytes of email and message storage.
Bragg Gaming Group Inc (CVE:BRAG) (OTCMKTS:BRGGF) said Wednesday that its subsidiary ORYX Gaming has strengthened its Romanian presence via a deal with casino operator Game World. The deal is the second turnkey solution agreement for ORYX in the European country, the company said in a statement. Gameworld.ro will now appear on ORYX’s iGaming platform, which supports online casinos, sports betting and lottery verticals. Game World will also have full access to ORYX Hub, which boasts an extensive selection of casino games from over 100 providers.
Q BioMed Inc (OTCQB:QBIO) has struck a global distribution partnership with Caligor Coghlan Pharma Services (CCPS), which will allow it to supply patients outside the United States with the firm's cancer bone pain drug Strontium89. The biotech unveiled the named patient program distribution agreement on Wednesday in a statement, adding that it expects to fulfill orders within the next 30 to 60 days. "We are very happy we can enable non-US physicians to prescribe a safe, effective and non-opioid treatment to their bone metastasis pain patients," said Denis Corin, chief executive at Q BioMed.
LeanLife Health Inc (CSE:LLP) revealed Wednesday that it has inked a letter of intent with Poland-based food and beverage giant FoodCare Group to build a distribution network for their products in Canada and the United States. Vancouver-based LeanLife Health, which is developing Omega-3 products as oil, powder or emulsion to be used as food additives, said the companies have set out “a six-month period to finalize agreements” during which FoodCare has committed exclusivity to LeanLife. In a statement, LeanLife CEO Stan Lis said: “We are extremely pleased to get FoodCare to sign a letter of intent with us. We believe that LeanLife can provide a great platform for servicing the American and Canadian markets on behalf of FoodCare.”
CytoDyn Inc (OTCQB:CYDY) announced Tuesday that its potential HIV pre-exposure prophylaxis (PrEP) drug leronlimab prevented transmission of the simian equivalent of the disease in a pre-clinical study of macaques. The study tested the impact of a macaque-equivalent leronlimab dose of 350 milligrams (mg) weekly or 700 mg bi-monthly in 18 macaques with Simian-Human Immunodeficiency Virus (SHIV). Results showed that the bi-monthly dose completely prevented rectal transmission of the disease. The study results were revealed at the 23rd International AIDS Conference in a presentation titled, “CCR5 antibody blockade protects rhesus macaques from rectal SHIV acquisition." The drug works by blocking CCR5, a cellular receptor that is important in HIV infection, tumor metastases and other diseases.
Mawson Resources Limited (TSE:MAW) (OTCPINK:MWSNF) has revealed it will kick off geophysics at its Redcastle gold project in the historic gold fields of Victoria, Australia this month followed by diamond drilling in late August or early September. Earlier this year, the Finland-focused firm struck a deal giving it access to three high-grade, Fosterville-style (shallow-orogenic or epizonal) exploration projects at Redcastle with numerous historic mines, that lacked drill testing to depth. Mawson secured the right to earn 70% at Redcastle by spending A$1 million over the next five years. Redcastle has never been drill tested beneath any of the historic high-grade mining areas and has 17 kilometres of combined high-grade vein strike untested below the water table, the company said.
Heritage Cannabis Holdings Corp (CSE:CANN) (OTCMKTS:HERTF) has said it is launching its Purefarma Hemplixer CBD tinctures in three Canadian provinces. Hemplixer’s full-spectrum CBD tinctures will be available in two concentrations and retail at between C$30 and $50 for 30ml bottles. The products are expected to launch over the summer in the British Columbia, Alberta and Manitoba, with additional markets expected to follow for all Heritage products. Purefarma products are manufactured through a proprietary process that extracts oils from biomass to produce formulations that maximize bioavailability and contain unique strain-specific characteristics.
Mota Ventures Corp (CSE:MOTA) (OTCPINK:PEMTF) CEO Ryan Hoggan said Wednesday that despite the “unprecedented uncertainties” thrown up by the coronavirus pandemic, the company achieved first-quarter business and financial targets in line with expectations. "In the midst of evolving challenges resulting from the global coronavirus outbreak, the company realigned priorities to focus on the health and safety of our employees, customers and suppliers. The way our team adapted and performed was exceptional,” Hoggan said in a statement accompanying the group's latest numbers. “Despite the unprecedented uncertainties resulting from the coronavirus, our operations and supply chains performed without interruption, and the company achieved targets in line with expectations. In order to capitalize on the global market, we recognize the need to be flexible and proactive in addressing market trends," he added.
PreveCeutical Medical Inc (CSE:PREV) (OTCQB:PRVCF) announced Wednesday that it has filed a provisional application at the Australian Patent Office with the aim of seeking protection for certain peptides analogues of dynorphin and their use in pain management. "Building a library of intellectual properties and having these protected is our Company's strategy,” PreveCeutical CEO Stephen Van Deventer said in a statement. “The provisional application filing for peptide IP will add tremendous value and building partnerships for commercialization of peptide-based therapies."
ImagineAR Inc (CSE:IP) (OTCMKTS:IPNFF), an augmented reality company that enables sports teams, businesses, retailers and organizations to instantly create their own AR mobile campaigns, said it has received more than $1.5 million from the exercise of warrants. The Vancouver-based company pointed out that that the proceeds will provide the financial resources necessary to fund growth and operations for a minimum of 12 months, assuming it were not able to generate any further revenue from business operations. However, ImagineAR said it expects meaningful revenue from its current and anticipated sales pipeline over the next 12 months, and it also expects to receive additional proceeds from further warrant exercises. The company so far in 2020 has raised total financing proceeds of about $3 million.
Dyadic International Inc (NASDAQ:DYAI) has entered into fully funded collaborations with two of the leading global animal health companies to demonstrate its proprietary C1 platform for expression and production of therapeutic proteins for companion and farm animal diseases. "We are very pleased to announce two new animal health-related research agreements with global leaders,” Dyadic CEO Mark Emalfarb said in a statement Wednesday. “Our efforts in animal health reinforce our highly targeted business development approach to large and growing global markets.”
Japan Gold Corp (CVE:JG) (OTCQB:JGLDF) has updated on the progress of its alliance with Barrick Gold, saying it has completed bulk leach extractable gold (BLEG) and rock chip samples at eight of the venture's 14 southern Kyushu projects and is awaiting sample results. The projects lie in the Hokusatsu region of Japan on the island of Kyushu. The region itself lies within the northern half of the southern Kyushu epithermal gold province, which is the country's largest gold producing region. The Barrick Alliance with Japan Gold was formed in February this year and spans 28 out of the firm's 30 current projects. Barrick will sole fund a two-year initial evaluation of each project and potentially a three-year second phase if they meet criteria.
GoviEx Uranium Inc (CVE:GXU) has said it it will appeal the decision of the Zambian government's mining department to terminate its Chirundu mining license in the African country. The license was acquired in late 2017 from African Energy Resources Ltd and includes the Njame and Gwabe deposits, noted GoviEx, which were subsequently included in the preliminary economic assessment (PEA) for the group's Mutanga uranium project. The study pegged the after-tax net present value (NPV) of US$112 million, at 8% discount rate with an internal rate of return (IRR) of 25%, using a long-term uranium price of US$58 per pound and a 9% mining royalty rate.
mCloud Technologies Corp (CVE:MCLD) (OTCQB:MCLDF) has said its annual user conference will be held virtually and look at how new technology can make businesses "better, faster and more resilient". In a statement on Wednesday, the artificial intelligence (AI) and IoT (Internet of Things) focused firm told investors that this year's mCloud Connect 2020 will be held from September 21 to 23 as a live-streamed virtual event. It will address the role that digital transformation and new connected technologies will play in operating assets and critical infrastructure in a post coronavirus (COVID-19) world.
Esports Entertainment Group Inc (NASDAQ:GMBL), an online gambling company focused on esports wagering and 18+ gaming, said Wednesday that it has tapped Akur Capital as its iGaming mergers and acquisitions advisor. Akur specializes in international mergers and acquisitions in the iGaming and sports betting industry. “We just signed with Akur and are already evaluating multiple potential M&A opportunities they’ve introduced to us,” Esports CEO Grant Johnson said in a statement. “The Akur team has years of iGaming and gambling experience and an extensive network of industry contacts. As the first US-based iGaming company to list on Nasdaq, we’re in a great position to capitalize on these highly fragmented markets and believe Akur will prove to be a valuable partner in our ongoing success.”
Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCMKTS:NSPDF) announced Wednesday that its Prosnack Natural Foods facility has passed one of the most rigorous food safety and quality audits in the industry. The Safe Quality Food (SQF) program operates within some of the highest standards in the food manufacturing industry and recognized by the Global Food Safety Initiative, Taken annually, the successful audit opens additional business opportunities for Naturally Splendid as many large retailers require that products on their shelves must meet SQF standards, the group pointed out. The Prosnack facility in British Columbia is a 20,000-square-foot manufacturing centre that produces nutritional bars and bites formulated primarily with plant-based ingredients.
Fidelity Minerals Corp. (CVE:FMN) (FSE:S5GM) (SSE:MNYC) said it has granted an aggregate of 1,925,000 incentive stock options to certain directors, officers and consultants of the company under its previously approved Stock Option Plan. The options are exercisable at a price of $0.075 per share for a period of 5 years and are subject to TSX Venture Exchange approval.
LexaGene Holdings, Inc. (CVE:LXG) (OTCQB:LXXGF), a molecular diagnostics company that develops genetic analyzers for rapid pathogen detection, has announced that it will host a webcast investor presentation on Tuesday, July 14, at 2.00pm ET. It said that, during the webcast, Dr Jack Regan, LexaGene’s CEO and founder, will provide an introductory presentation through a PowerPoint discussion that will cover key areas of LexaGene’s business, including an overview of the company’s proprietary technology, target markets and opportunity, competitive advantages, growth strategy, and anticipated milestones. Following the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal. To listen to the webcast or to ask questions during the live event, investors should pre-register at the following link: https://event.webcasts.com/starthere.jsp?ei=1294081&tp_key=b029bb1560. An archived version of the webcast and presentation will be available on the investor relations section of the company’s website following the event.
Vendetta Mining Corp (CVE:VTT) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement announced on February 11, 2020, April 20, 2020, and May 6, 2020, which will see the issue of 20,288,188 shares at a purchase price of 4 cents each, together with 20,288,188 share purchase warrants at an exercise price of 6 cents for a three-year period with 46 placees.
mCloud Technologies Corp (CVE:MCLD) has said that, effective July 6, 2020, the company's final prospectus supplement, dated June 26, 2020, qualifying the distribution of 3,150,686 units of the company (including the exercise of the overallotment option), was filed with and accepted by the TSX Venture Exchange at a price of $3.65 per unit for gross proceeds of $11,500,003.
The International Speculator, in its June 24, 2020, issue, says buy VR Resources Ltd. (CVE:VRR) at 30 cents, officially, Buy up to 30 cents. The newsletter said buy on July 24, 2019, at 13.5 cents. Assuming an investment of $1,000, the holding is worth $2,200.